ArticleEuropean journal of immunology2018

TMP778, a selective inhibitor of RORγt, suppresses experimental autoimmune uveitis development, but affects both Th17 and Th1 cell populations.

Cancan Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.